Ruling May Hinder Smokers' Class Action Suit

Publication
Article
Oncology NEWS InternationalOncology NEWS International Vol 4 No 5
Volume 4
Issue 5

CHICAGO--A ruling by the US Court of Appeals for the Seventh Circuit may put a damper on the class action suit filed in a federal court in Louisiana against tobacco manufacturers.

CHICAGO--A ruling by the US Court of Appeals for the Seventh Circuitmay put a damper on the class action suit filed in a federal courtin Louisiana against tobacco manufacturers.

The judges ruled that since the 50 states have different lawson negligence, a class action trial that would require adoptionof a single legal standard on negligence is disallowed. The rulingreversed a lower court decision allowing the suit by some 10,000hemophiliacs or their surviving families against drug manufacturerswho, they say, knowingly distributed blood clotting factor contaminatedwith HIV.

The smokers' class action suit--the Castano case--names four plaintiffsintended to represent all US smokers, former smokers, and theirsurviving families. The seven tobacco companies named in the suithave appealed to the Fifth Circuit Court to disallow the classaction, which was permitted in a February ruling by a FederalDistrict judge.

Newsletter

Stay up to date on recent advances in the multidisciplinary approach to cancer.

Recent Videos
“It’s a drug that I’m very comfortable with, and it is a drug I’ll likely use primarily in the first-line setting,” stated Jorge Nieva, MD, on taletrectinib in non–small cell lung cancer.
4 experts in this video
4 experts in this video
Those being treated for peritoneal carcinomatosis may not have to experience the complication rates or prolonged recovery associated with surgical options.
For patients with peritoneal carcinomatosis, integrating PIPAC into a treatment regimen does not interrupt their systemic therapy.